MBL77 NO FURTHER A MYSTERY

mutations supplied The point that, as explained beneath, CLL therapy is predicated to the presence or absence of these mutations. The current consensus is the fact that, aside from clonal mutations, subclonal mutations that has a variant allelic frequency starting from 5 to ten% (and therefore beneath the threshold of detection by typical molecular